Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

A Phase I Clinical Study of the Safety, Tolerability and Pharmacokinetics of HX-1171 in Healthy Male Subjects. (HX-1171)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT01889745
Expanded Access Status : Temporarily not available
First Posted : June 28, 2013
Last Update Posted : June 28, 2013
Sponsor:
Information provided by (Responsible Party):
Biotoxtech Co., Ltd

Tracking Information
First Submitted Date June 20, 2013
First Posted Date June 28, 2013
Last Update Posted Date June 28, 2013
 
Descriptive Information
Brief Title A Phase I Clinical Study of the Safety, Tolerability and Pharmacokinetics of HX-1171 in Healthy Male Subjects.
Brief Summary This study is designed to multiple dose and dose escalation study
Detailed Description A Phase I Clinical Study, Randomized, Single-blind, Placebo-controlled, Single Dose Escalation Study of the Safety, Tolerabiluty, and Pharmacokinetics of HX-1171 in Healthy Male Subjects
Study Type Expanded Access
Intervention Drug: HX-1171
Anti-oxidatant, Anti-inflamation
Other Names:
  • 1-O-hexyl-2,3,5-trimethylhydroquinone
  • HX-1171 500mg
Publications * Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Recruitment Information
Expanded Access Status Temporarily not available
Contacts Contact information is only displayed when the study is recruiting subjects
Listed Location Countries Korea, Republic of
Removed Location Countries  
 
Administrative Information
NCT Number NCT01889745
Responsible Party Biotoxtech Co., Ltd
Study Sponsor Biotoxtech Co., Ltd
Collaborators Not Provided
Investigators
Principal Investigator: Kyun-Seop Bae, M.D., Ph.D Asan Medical Center
PRS Account Biotoxtech Co., Ltd
Verification Date June 2013